共 63 条
[1]
Hauser W.A., Hesdorffer D., Epilepsy, Frequency, Causes and Consequences, (1990)
[2]
Wiebe S., Bellhouse D.R., Fallahay C., Eliasziw M., Burden of epilepsy: the Ontario Health Survey, Can J Neurol Sci, 26, 4, pp. 263-270, (1999)
[3]
Sperling M.R., The consequences of uncontrolled epilepsy, CNS Spectr, 9, 2, pp. 98-101, (2004)
[4]
Jones M.W., Consequences of epilepsy: why do we treat seizures?, Can J Neurol Sci, 25, 4, pp. S24-S26, (1998)
[5]
Dickenson A.H., Ghandehari J., Anti-convulsants and anti-depressants, Handb Exp Pharmacol, 177, pp. 145-177, (2007)
[6]
Stefani A., Spadoni F., Bernardi G., Voltage-activated calcium channels: targets of antiepileptic drug therapy?, Epilepsia, 38, 9, pp. 959-965, (1997)
[7]
Snutch T.P., Reiner P.B., Ca2+ channels: diversity of form and function, Curr Opin Neurobiol, 2, 3, pp. 247-253, (1992)
[8]
Spina E., Perugi G., Antiepileptic drugs: indications other than epilepsy, Epileptic Disord, 6, 2, pp. 57-75, (2004)
[9]
Harden C.L., Pennell P.B., Koppel B.S., Hovinga C.A., Gidal B., Meador K.J., Hopp J., Ting T.Y., Hauser W.A., Thurman D., Kaplan P.W., Robinson J.N., French J.A., Wiebe S., Wilner A.N., Vazquez B., Holmes L., Krumholz A., Finnell R., Shafer P.O., Le Guen C.L., Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: report of the quality standards subcommittee and therapeutics and technology assessment
[10]
Harden C.L., Meador K.J., Pennell P.B., Hauser W.A., Gronseth G.S., French J.A., Wiebe S., Thurman D., Koppel B.S., Kaplan P.W., Robinson J.N., Hopp J., Ting T.Y., Gidal B., Hovinga C.A., Wilner A.N., Vazquez B., Holmes L., Krumholz A., Finnell R., Hirtz D., Le Guen C., Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the